Endovantage Overview

  • Founded
  • 2013
  • Status
  • Acquired/​Merged
  • Employees
  • 9
  • Latest Deal Type
  • M&A

Endovantage General Information


Developer of a cloud-based computational platform designed to automate comprehensive cerebral aneurysm management. The company's platform uses a patient's medical scan to create a personalized 3D model of the vasculature and provides accurate, clinically relevant information for aneurysm treatment, enabling doctors to take decision accordingly and treat patients.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Parent Company
Primary Office
  • 8444 North 90th Street
  • Suite 125
  • Scottsdale, AZ 85258
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endovantage Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 09-Jun-2020 00.000 Completed Generating Revenue
6. Angel (individual) 01-Aug-2015 000 00.000 0000 Completed Startup
5. Grant 01-Mar-2015 00000 0000 Completed Startup
4. Accelerator/Incubator 01-May-2014 0000 0000 Completed Startup
3. Accelerator/Incubator 19-Feb-2014 000 Completed Startup
2. Accelerator/Incubator 05-Sep-2013 $3K $3K Completed Startup
1. Grant 29-May-2013 $3.47M Completed Startup
To view Endovantage’s complete valuation and funding history, request access »

Endovantage Executive Team (4)

Name Title Board Seat Contact Info
Brian Chong MD Co-Founder, Board Member & Chief Medical Officer
David Frakes Ph.D Co-Founder, Board Member & Chief Science Officer
Haithem Babiker Ph.D Co-Founder, Board Member & Chief Technology Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Endovantage Board Members (3)

Name Representing Role Since
Brian Chong MD Endovantage Co-Founder, Board Member & Chief Medical Officer 000 0000
David Frakes Ph.D Endovantage Co-Founder, Board Member & Chief Science Officer 000 0000
Haithem Babiker Ph.D Endovantage Co-Founder, Board Member & Chief Technology Officer 000 0000
To view Endovantage’s complete board members history, request access »

Endovantage Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endovantage Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ASU-Mayo Seed Grant Other 000 0000 000000 0
American Heart Association Corporation 000 0000 000000 0
Arizona Innovation Challenge Not-For-Profit Venture Capital 000 0000 000000 0
Brain Aneursym Foundation Other 000 0000 000000 0
Desert Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »